LIBERVANT
LIVE

Serial Number

90309531

Owner

AQUESTIVE THERAPEUTICS, INC.

Attorney

Carrie Webb Olson

First Use Date

Apr 29, 2024

Filing Date

Nov 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LIBERVANT Trademark

Serial Number: 90309531 • Registration: 7502636

LIBERVANT is a trademark filed by AQUESTIVE THERAPEUTICS, INC. on November 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AQUESTIVE THERAPEUTICS, INC. (82 trademarks)

30 Technology Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

November 10, 2020

Registration Date

September 10, 2024

First Use Anywhere

April 29, 2024

First Use in Commerce

April 29, 2024

Published for Opposition

April 27, 2021

Goods & Services

Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 10, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 8, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 8, 2024 CNPR
ASSIGNED TO EXAMINER
Aug 6, 2024 DOCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 26, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2024 REAP
STATEMENT OF USE PROCESSING COMPLETE
Jun 20, 2024 SUPC
USE AMENDMENT FILED
Jun 18, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 18, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 28, 2023 EXRA
SOU EXTENSION 5 GRANTED
Nov 25, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 25, 2023 AITU
SOU EXTENSION 5 FILED
Nov 13, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 30, 2023 EX4G
SOU EXTENSION 4 FILED
May 30, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 30, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2022 EXRA
SOU EXTENSION 3 GRANTED
Dec 14, 2022 EX3G
SOU EXTENSION 3 FILED
Dec 14, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 14, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 25, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 31, 2022 EX2G
SOU EXTENSION 2 FILED
May 31, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 31, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 16, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 16, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 16, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 22, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2021 CNSA
ASSIGNED TO EXAMINER
Mar 15, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2021 NWOS
NEW APPLICATION ENTERED
Nov 13, 2020 NWAP